Speaker:
Hojin Moon
Division of Biometry & Risk
Assessment
U.S. Food and Drug Administration
Time and Place:
3:30 p.m., November 10, Allen 14
Title:
Ensemble methods for classification of patients for personalized medicine
with high-dimensional data
Abstract:
Classification methods are commonly used for prediction of response to
therapy to help individualize clinical assignment of treatment. The methods
are required to be highly accurate for optimal treatment on each patient.
Typically, there are numerous genomic and clinical variables over a
relatively small number of patients, which presents challenges for most
traditional classification methods to avoid over-fitting the data. We
developed a robust classification method for high-dimensional data based on
ensembles of classifiers from the optimal number of random partitions. The
proposed method is applied to genomic data sets on lymphoma patients and
lung cancer patients to distinguish disease subtypes for optimal treatment
and to genomic data on breast cancer patients to identify patients most
likely to benefit from adjuvant chemotherapy after surgery. The performance
of the proposed method is consistently good or better compared to the other
classification algorithms. We find that the predictive accuracy can be
improved by adding some relevant demographic, clinical and/or
histopathological measurements to the genomic data.
Refreshments: 3:00 - 3:30, Allen 467
Host:
Dongfeng Wu, (662) 325-7150,
dwu@math.msstate.edu
|
|